China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Describe the key pathological features of pancreatic cancer TLS and establish a quantitative system for these pathological features'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136296

Registration Time: 2026/11/09

Type: Observational study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343989

Published by HT Digital Content Services with permission from Health Daily Digest....